PDPN and neoplasm: Finally, our data revealed that p38 MAPK inhibition cooperates with cisplatin treatment and promotes apoptosis in podoplanin-labeled pEMT tumor cells (9.74% vs. 2.56%) (Figure 4E vs. Figure 4C).